Smart Patients Get Smart Care™

The World’s Leading Authority for Chronic Lymphocytic Leukemia Patients

Next-Generation CLL Treatments: Understanding Clinical Trials and Future Therapeutic Strategies

Wednesday, July 16, 2025 at 12:30 – 2 PM PT, 1:30 – 3 PM MT, 2:30 – 4 PM CT, 3:30 – 5 PM ET
 (Duration 90 minutes)

Description

Join us for an insightful webinar featuring Dr. Jennifer R. Brown who will delve into the latest advancements in CLL treatment, focusing on emerging therapies currently under investigation in clinical trials. Drawing from her extensive knowledge and clinical experience, she will provide an overview of novel treatment strategies, including combination therapies, and discuss their potential impact on patient outcomes for first line and relapsed refractory options. Attendees will gain a comprehensive understanding of the current CLL treatment landscape, insights into ongoing clinical trials, and the future direction of CLL therapy. This webinar is essential for people seeking to stay informed about cutting-edge developments in CLL management and a better understanding of the clinical trial process.

This webinar and discussion will be slightly advanced, but we invite everyone to join and learn.

Speakers

Welcome:
RB Headshot 2_Color_July 2023

Robyn Brumble, MSN, RN
Director of Scientific Affairs & Research
CLL Society

Moderator:
Terry Evans - CLL Society

Terry Evans
Patient Advocate
Director, CLL Society Support Network

Speaker:
Jennifer Brown - CLL Society

Jennifer R Brown, MD, PhD
Worthington and Margaret Collette Professor of Medicine in the Field of Hematologic Oncology
Harvard Medical School
Director, CLL Center, and Institute Physician
Dana-Farber Cancer Institute

Advanced Questions:

Ask your question in advance of the event by emailing [email protected] by Monday, July 14th. Please include “CLL Treatment Webinar” in the subject line.

Questions asked in advance are provided to the speaker in preparation for the event. Questions that are applicable to more than one person and succinctly written to have broad interest have a higher chance of being asked by the moderator.

Find CLL Society on Social Media

Follow CLL Society on Facebook @CLLSociety as well as other social media platforms below.

This program was made possible by generous donors and grant support from BeOne, Genentech, and Lilly.